Search

everythinglearnresearchcommunity

for

Search:↓

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Multiple treatments work best for hair loss.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Melatonin improves cashmere goat hair growth and quality by increasing antioxidants and reducing cell death.

New genes found linked to balding, may help develop future treatments.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Mutations in the PTPRQ gene cause significant balance issues in mice due to hair bundle defects in the inner ear.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.